Tri Chemical Laboratories Inc. (TYO:4369)
Japan
· Delayed Price · Currency is JPY 2,808.00
+45.00 (1.63%)
Jun 10, 2025, 3:30 PM JST
Tri Chemical Laboratories Income Statement
Financials in millions JPY. Fiscal year is February - January.
Millions JPY. Fiscal year is Feb - Jan.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 30, 2025 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 | Jan '21 Jan 31, 2021 | 2016 - 2020 |
| Revenue | 22,201 | 18,905 | 11,246 | 13,803 | 11,574 | 9,801 | Upgrade
|
| Revenue Growth (YoY) | 96.61% | 68.10% | -18.52% | 19.26% | 18.09% | 18.56% | Upgrade
|
| Cost of Revenue | 12,956 | 10,894 | 7,160 | 8,224 | 6,740 | 5,421 | Upgrade
|
| Gross Profit | 9,245 | 8,011 | 4,086 | 5,579 | 4,834 | 4,380 | Upgrade
|
| Selling, General & Admin | 2,941 | 2,031 | 1,410 | 1,439 | 1,305 | 1,177 | Upgrade
|
| Research & Development | - | 660 | 665 | 569 | 486 | 452 | Upgrade
|
| Operating Expenses | 2,941 | 2,755 | 2,138 | 2,074 | 1,858 | 1,689 | Upgrade
|
| Operating Income | 6,304 | 5,256 | 1,948 | 3,505 | 2,976 | 2,691 | Upgrade
|
| Interest Expense | -24.47 | -23 | -23 | -28 | -31 | -34 | Upgrade
|
| Interest & Investment Income | 6.4 | 2 | 1 | - | - | - | Upgrade
|
| Earnings From Equity Investments | 1,256 | 1,309 | 1,036 | 2,409 | 1,936 | 1,540 | Upgrade
|
| Currency Exchange Gain (Loss) | -425.84 | - | 330 | - | 300 | - | Upgrade
|
| Other Non Operating Income (Expenses) | 39 | 38 | 8 | 300 | 129 | 144 | Upgrade
|
| EBT Excluding Unusual Items | 7,155 | 6,582 | 3,300 | 6,186 | 5,310 | 4,341 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | - | - | -9 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | -24 | - | -16 | -9 | Upgrade
|
| Pretax Income | 7,155 | 6,582 | 3,276 | 6,186 | 5,294 | 4,323 | Upgrade
|
| Income Tax Expense | 1,798 | 1,621 | 806 | 1,354 | 1,199 | 946 | Upgrade
|
| Net Income | 5,357 | 4,961 | 2,470 | 4,832 | 4,095 | 3,377 | Upgrade
|
| Net Income to Common | 5,357 | 4,961 | 2,470 | 4,832 | 4,095 | 3,377 | Upgrade
|
| Net Income Growth | 133.94% | 100.85% | -48.88% | 18.00% | 21.26% | 14.90% | Upgrade
|
| Shares Outstanding (Basic) | 32 | 32 | 32 | 32 | 32 | 31 | Upgrade
|
| Shares Outstanding (Diluted) | 32 | 32 | 32 | 32 | 32 | 31 | Upgrade
|
| Shares Change (YoY) | - | - | - | 0.25% | 3.74% | - | Upgrade
|
| EPS (Basic) | 164.86 | 152.66 | 76.01 | 148.69 | 126.33 | 108.07 | Upgrade
|
| EPS (Diluted) | 164.86 | 152.66 | 76.01 | 148.69 | 126.33 | 108.07 | Upgrade
|
| EPS Growth | 133.94% | 100.85% | -48.88% | 17.70% | 16.89% | 14.90% | Upgrade
|
| Free Cash Flow | -1,100 | 606 | 1,233 | 4,862 | 2,757 | -835 | Upgrade
|
| Free Cash Flow Per Share | -33.86 | 18.65 | 37.94 | 149.61 | 85.05 | -26.72 | Upgrade
|
| Dividend Per Share | 35.000 | 35.000 | 30.000 | 30.000 | 20.000 | 17.000 | Upgrade
|
| Dividend Growth | 16.67% | 16.67% | - | 50.00% | 17.65% | 17.24% | Upgrade
|
| Gross Margin | 41.64% | 42.38% | 36.33% | 40.42% | 41.77% | 44.69% | Upgrade
|
| Operating Margin | 28.40% | 27.80% | 17.32% | 25.39% | 25.71% | 27.46% | Upgrade
|
| Profit Margin | 24.13% | 26.24% | 21.96% | 35.01% | 35.38% | 34.46% | Upgrade
|
| Free Cash Flow Margin | -4.96% | 3.21% | 10.96% | 35.22% | 23.82% | -8.52% | Upgrade
|
| EBITDA | 7,747 | 6,628 | 3,252 | 4,714 | 3,995 | 3,505 | Upgrade
|
| EBITDA Margin | 34.89% | 35.06% | 28.92% | 34.15% | 34.52% | 35.76% | Upgrade
|
| D&A For EBITDA | 1,443 | 1,372 | 1,304 | 1,209 | 1,019 | 814 | Upgrade
|
| EBIT | 6,304 | 5,256 | 1,948 | 3,505 | 2,976 | 2,691 | Upgrade
|
| EBIT Margin | 28.40% | 27.80% | 17.32% | 25.39% | 25.71% | 27.46% | Upgrade
|
| Effective Tax Rate | 25.12% | 24.63% | 24.60% | 21.89% | 22.65% | 21.88% | Upgrade
|
Updated Mar 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.